Chip-level AI Licensing Partnership Commercial Production
Filed with ASX · · 4 pages · English
Summary by 6ix AI
Audeara Ltd. has announced that its chip-level AI licensing partnership with Optek has entered commercial production across two customer product programs, marking a significant milestone for the company. This successful deployment validates Audeara's strategy of licensing its AI technologies to semiconductor partners and demonstrates its ability to integrate these technologies efficiently. Audeara's CEO emphasized the importance of this milestone, highlighting the competitive advantage gained through the successful on-chip deployment of their technology.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Audeara
- Q4 FY26 Quarterly Activities Report & Appendix 4C
- Audeara Secures Exclusive Deal with Shokz Health Global
- Q3 FY26 Quarterly Activities Report & Appendix 4C
- Auracast platform expansion underway with Clinico Inc
- Appendix 4D & Half-Year Financial Report to 31 December 2025
Later from Audeara
- Firm commitments of $1.26m received via Placement
- Appendix 4E and Annual Report 2026
- Q1 FY27 Quarterly Activities Report & Appendix 4C
Follow Audeara into a list and get an email when it puts out news.
Follow Audeara